International Stem Cell Corporation
ISCO
$0.36
-$0.01-3.06%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -141.49% | -52.19% | -100.00% | 91.30% | 64.77% |
| Total Depreciation and Amortization | -20.83% | -6.60% | 6.31% | 9.50% | 11.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.74% | -17.67% | -4.48% | -16.01% | -17.87% |
| Change in Net Operating Assets | 90.94% | -62.60% | 28.18% | -435.94% | -57.25% |
| Cash from Operations | 235.45% | -122.63% | -38.46% | -139.52% | 107.55% |
| Capital Expenditure | 52.00% | 62.58% | 74.10% | 75.15% | 47.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.00% | -150.00% | 60.00% | 66.67% | -66.67% |
| Cash from Investing | 37.50% | 57.49% | 73.68% | 74.85% | 44.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 62.50% | -75.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.50% | -75.00% | 0.00% | 0.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.68% | -886.36% | 33.80% | -177.24% | -302.17% |